Synapse - Jakob Dupont

Results (65)

Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy

Journal Article

Sabbatini, P.; Mooney, D.; Iasonos, A.; Thaler, H.; Aghajanian, C.; Hensley, M.; Konner, J.; Spriggs, D.; Abu-Rustum, N. R.; Dupont, J.
International Journal of Gynecological Cancer (2007)

Fulltext@MSK | Save

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy

Journal Article

Juretzka, M. M.; Barakat, R. R.; Chi, D. S.; Iasonos, A.; Dupont, J.; Abu-Rustum, N. R.; Poynor, E. A.; Aghajanian, C.; Spriggs, D.; Hensley, M. L.; more...
Gynecologic Oncology (2007)

Fulltext@MSK | Save

A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors

Journal Article

Hensley, M. L.; Dizon, D.; Derosa, F.; Venkatraman, E.; Sabbatini, P.; Chi, D. S.; Dupont, J.; Colevas, A. D.; Spriggs, D.; Aghajanian, C.
Investigational New Drugs (2007)

Fulltext@MSK | Save

Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses

Journal Article

Fricke, I.; Mirza, N.; Dupont, J.; Lockhart, C.; Jackson, A.; Lee, J. H.; Sosman, J. A.; Gabrilovich, D. I.
Clinical Cancer Research (2007)

Fulltext@MSK | Save

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer

Journal Article

Diefenbach, C. S. M.; Shah, Z.; Iasonos, A.; Barakat, R. R.; Levine, D. A.; Aghajanian, C.; Sabbatini, P.; Hensley, M. L.; Konner, J.; Tew, W.; more...
Gynecologic Oncology (2007)

Fulltext@MSK | Save

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas

Journal Article

Aghajanian, C.; Burris, H. A. 3rd; Jones, S.; Spriggs, D. R.; Cohen, M. B.; Peck, R.; Sabbatini, P.; Hensley, M. L.; Greco, F. A.; Dupont, J.; more...
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

MUC16 gene expression inhuman oarian cncer cells and Cisplatin, resistance

Meeting Abstract

Thapi, D.; Kehoe, S. M.; Eisenhauer, E.; Boyd, J.; Dupont, J.; Spriggs, D. R.
Cancer Research (2006)

Fulltext@MSK | Save

Pharmacodynamic case study of sunitinib/SU11248 in a gastrointestinal stromal tumor patient: Evidence toward a mechanism of effect

Meeting Abstract

Seandel, M.; Shia, J.; Linkov, I.; Maki, R. G.; Antonescu, C.; Dupont, J.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Phase I study of MORAb-003, a humanized anti-folate receptor-alpha monoclonal antibody, in platinum resistant ovarian cancer

Meeting Abstract

Konner, J. A.; Ahmed, S.; Gerst, S.; Els, N. V.; Pezzulli, S.; Sabbatini, P.; Hensley, M.; Dupont, J.; Tew, W.; Aghajanian, C.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

A phase I study of pemetrexed (P) plus gemcitabine (G) in relapsed ovarian cancer (OC): Dosing results and evidence of activity

Meeting Abstract

Hensley, M. L.; Derosa, F.; Gerst, S. R.; Sabbatini, P.; Dupont, J.; Konner, J.; Goss, T.; Orlando, M.; Wang, Y.; Aghajanian, C.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save